Furthermore, emerging molecular studies suggest that some APTs share genomic features with parathyroid carcinomas, particularly in the presence of CDC73 alterations, supporting the idea that APTs may fall somewhere between benign and malignant parathyroid tumors rather than being a clearly separate category (Pardi et al. 2024). This evidence concerns the gene CDC73 and cancer.